We are excited to confirm that the first IAP focus area will address strategies to improve states substance use disorder (SUD) treatment systems. SUD is a serious and growing problem in the U.S., but evidence is also strong for the efficacy and cost-effectiveness of treatment. Based on...
We had a great in-person meeting on Monday in Baltimore with over 25 representatives from states joining us in the morning and an equal number of consumer advocates and providers for the afternoon session. We were thrilled with the thoughtful discussion and helpful feedback. As we hoped, these...
This week, we are hosting the first in a series of in-person meetings across the country to begin the conversation about our Medicaid Innovation Accelerator Program (IAP), a new initiative that we are launching in partnership with the Center for Medicare and Medicaid Innovation. We launched...
IAP CMS Commentary